NEW YORK (GenomeWeb News) - Rosetta Genomics said today it has licensed PCR technology from Roche Molecular Diagnostics for use in its microRNA-based diagnostic tests.
The company plans to use the PCR technology in its efforts to identify microRNA biomarkers in several different sample types and body fluids.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.